Healthy Clinical Trial - A First-in-human Study of Multiple Doses of

Clinical Trial Summary

The purpose of the study is to evaluate the safety, (local and systemic) tolerability, and pharmacokinetics following multiple doses of topically applied, maximum feasible formulations of PF-07295324 (0.12% w/w) or PF-07259955 (2% w/w), on approximately 20% body surface area (BSA), in healthy adult participants.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04632485` - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Terminated	`NCT04556032` - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women	N/A
Completed	`NCT04107441` - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects	Phase 1
Completed	`NCT04998695` - Health Effects of Consuming Olive Pomace Oil	N/A
Completed	`NCT04065295` - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225	Phase 1
Completed	`NCT01442831` - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects	Phase 1
Recruiting	`NCT05515328` - A Study in Healthy Men to Test How BI 685509 is Processed in the Body	Phase 1
Recruiting	`NCT04967157` - Cognitive Effects of Citicoline on Attention in Healthy Men and Women	N/A
Completed	`NCT05030857` - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects	Phase 1
Recruiting	`NCT04494269` - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls	Phase 1
Recruiting	`NCT04714294` - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers	Phase 1
Completed	`NCT04539756` - Writing Activities and Emotions	N/A
Recruiting	`NCT04098510` - Concentration of MitoQ in Human Skeletal Muscle	N/A
Completed	`NCT03308110` - Bioavailability and Food Effect Study of Two Formulations of PF-06650833	Phase 1
Completed	`NCT04052711` - A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design	Phase 1
Terminated	`NCT00001844` - Study of New Magnetic Resonance Methods
Completed	`NCT04451811` - A PK Dose Proportionality Study of OPL-002 in Healthy Volunteers	Phase 1
Completed	`NCT04319926` - Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects	Phase 1
Completed	`NCT03160261` - Effect of Exenatide on Cortisol Secretion	Phase 4
Completed	`NCT05392816` - Non-heme Iron Absorption From Single Meals of Fava Bean Protein, Beef Protein and Cod Protein	N/A

NCT number	NCT05206604
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 1
Start date	February 9, 2022
Completion date	August 12, 2022

A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms